2050
M. Jankowska, J. Madaj / Carbohydrate Research 340 (2005) 2048–2051
0
11.2, J6,6 2.0, H-6), 3.59 (t, 1H, J3,4 8.8, J4,5 10.0, H-4),
0.87 (s, 9H, Si–C–(CH3)3) 0.01 (s, 3H, Si(CH3)2), 0.01 (s,
3H, Si(CH3)2). 13C NMR d 138.89–127.14 (Ph), 87.05
(C-1), 82.76 (C-3), 80.30 (C-2), 77.64 (C-4), 76.07
(OCH2Ph), 75.30 (OCH2Ph), 72.87 (C-5), 72.67
(OCH2Ph), 62.48 (C-6), 26.16 (Si–C–(CH3)3), 18.57
(Si–C–(CH3)3), ꢀ4.96 (Si(CH3)2), ꢀ5.20 (Si(CH3)2).
This compound was used directly in synthesis as
described in Sections 1.5.1, 1.5.2, 1.6.1, 1.6.2, 1.6.3 and
1.7.1, which follow.
(C-6II), 70.31 (C-5I), 69.26 (C-6I), 68.7 (OCH2), 62.92
(C-5II), 52.27 (C-2I), 23.26 (NHCOCH3). Anal. Calcd
for C52H57NO11: C, 71.64; H, 6.54; N, 1.6. Found: C,
70.95; H, 6.87; N, 1.01.
1.5.2. Procedure C. The mixture after the reaction of 9
(0.12 g, 0.34 mM) with 211 (0.26 g, 0.41 mM) in DMF
(10 mL) and CH2Cl2 (10 mL) in the presence of NIS
(0.1 g) and TMSOTf (30 lL) was eluted from a column
of silica gel with 1:2 EtOAc–toluene to give 10 (0.07 g,
24%) as an oil. The compound was identical to that from
Procedure A, above.
1.4. Phenyl 2,3,4-tri-O-benzyl-1-thio-6-O-trityl-a-D-
glucopyranoside (8)
1.6. Allyl 6-O-acetyl-2,3,4-tri-O-benzyl-a-D-gluco-
pyranosyl-(1!3)-2-acetamido-4,6-O-benzylidene-
2-deoxy-a-D-glucopyranoside (11)
Sodium hydride (65 mg, 2.71 mM) was added to a
cooled solution of phenyl 1-thio-6-O-trityl-a-D-gluco-
pyranoside4 (0.12 g, 0.23 mM) in dry DMF (4 mL) and
the mixture was stirred for 1 h at 0 °C. Next BnBr
(0.14 mL; 1.4 mM) was added dropwise and the mixture
was stirred. After 2 h, excess of sodium hydride was
decomposed with MeOH and the mixture was concen-
trated. The residue was eluted from a column of silica
gel with 3:7 acetone–hexanes to give 8 (0.14 g, 78%) as
1.6.1. Procedure A. The mixture after the reaction of 9
(0.17 g, 0.49 mM) with 312 (0.39 g, 0.61 mM) in DMF
(15 mL) and CH2Cl2 (15 mL) in the presence of
TMSOTf (0.16 mL; 0.89 mM) was eluted from a column
of silica gel with 2:3 EtOAc–toluene to give 11 (0.18 g,
20
D
45%) as an oil: ½aꢁ +66 (c 1.4, CHCl3); 1H NMR
1
an oil: H NMR (CDCl3): d 7.61–6.95 (m, 35H, Ph),
(CDCl3): d 7.40–6.90 (m, 20H, Ph), 6.0 (d, 1H, NH),
5.89 (m, 1H, @CH), 5.49 (d, 1H, J1,2 3.6 H-1II), 5.44
(s, 1H, CHPh), 5.32 (m, 2H, @CH2), 4.97 (d, 1H,
OCH2Ph), 4.89 (d, 1H, J1,2 4.0, H-1I), 4.87 (d, 1H,
OCH2Ph), 4.77 (d, 1H, OCH2Ph), 4.53 (m, 2H,
OCH2Ph), 4.48 (m, 1H, H-2I), 4.3 (d, 1H, OCH2Ph),
4.74 (s, 1H, J1,2 4.8, H-1), 4.97–4.77 (m, 4H, OCH2Ph),
4.71–4.65 (m, 2H, OCH2Ph), 3.80–3.43 (m, 6H, H-5,
H-2, H-3, H-60, H-6, H-4). 13C NMR d 144.72–126.52
(Ph), 87.62 (C-1), 86.94 (C(C6H5)3), 81.01 (C-3), 79.27
(C-2), 77.99 (C-4), 76.03 (OCH2Ph), 75.62 (OCH2Ph),
75.25 (OCH2Ph), 73.60 (C-5), 69.20 (C-6).
4.27–4.16 (m, 4H, H-3I, H-5II, H-6II, OCH2), 4.12
0
(m, 2H, H-4I, H-6II ), 4.04 (m, 1H, OCH2), 3.95 (m,
0
1.5. Allyl 2,3,4,6-tetra-O-benzyl-a-D-glucopyranosyl-
(1!3)-2-acetamido-4,6-O-benzylidene-2-deoxy-a-D-
glucopyranoside (10)
3H, H-3II, H-6I, H-6I ), 3.77 (m, 1H, J4,5 9.6, J5,6 10.4,
H-5I), 3.38 (dd, 1H, J2,3 9.2, H-2II), 3.25 (t, 1H, J3,4
9.2, J4,5 9.6, H-4II), 2.08 (s, 3H, COCH3), 2.02 (s, 3H,
NCOCH3). 13C NMR d 171.18 (COCH3), 170.35
(NCOCH3), 138.86 (@CH), 138.27–126.61 (Ph), 118.72
(@CH2), 102.41 (CHPh), 97.66 (C-1I), 96.09 (C-1II),
83.22 (C-3II), 81.48 (C-4I), 79.32 (C-2II), 78.64
(C-4II), 75.9 (OCH2Ph), 74.77 (OCH2Ph), 72.06
(C-5II), 71.15 (OCH2Ph), 69.20 (C-5I), 68.91 (OCH2),
68.31 (C-3I), 64.58 (C-6II), 62.99 (C-6I), 51.86 (C-2I),
23.31 (COCH3), 21.15 (NHCOCH3). MALDITOF-MS:
Calcd for C47H53NO12: 823.9 [M]. Found: 846.3
[M+Na]+.
1.5.1. Procedure A. The mixture after the reaction of 9
(0.19 g, 0.54 mM) with 110 (0.47 g, 0.68 mM) in DMF
(17 mL) and CH2Cl2 (17 mL) in the presence of
TMSOTf (0.12 mL, 0.69 mM) was eluted from a column
of silica gel with 1:2 EtOAc–toluene to give 10 (0.33 g,
20
D
70%) as an oil: ½aꢁ +50 (c 1, CHCl3); 1H NMR
(CDCl3): d 7.41–7.24 (m, 25H, Ph), 6.25 (d, 1H, NH),
5.77 (m, 1H, @CH), 5.44 (d, 1H, J1,2 4.0, H-1II), 5.42
(s, 1H, CHPh), 5.21 (m, 2H, @CH2), 4.94 (d, 1H,
OCH2Ph), 4.87 (d, 1H, J1,2 3.2, H-1I), 4.81 (d, 1H,
OCH2Ph), 4.70 (d, 1H, OCH2Ph), 4.5 (m, 3H,
OCH2Ph), 4.39 (m, 1H, H-2I), 4.24 (m, 3H, H-3I, H-
1.6.2. Procedure B. The mixture after the reaction of 9
(0.20 g, 0.57 mM) with 412 (0.25 g, 0.88 mM) in DMF
(15 mL) and CH2Cl2 (15 mL) in the presence of AgOTf
(0.40, 1.56 mM) was eluted from a column of silica gel
with 2:3 EtOAc–toluene to give 11 (0.13 g, 28%) as an
oil. The compound was identical to that from Procedure
A, above.
0
0
6II , OCH2Ph), 4.20 (m, 2H, H-6I , OCH2), 3.85 (m,
4H, H-3II, H-4I, H-5II, OCH2), 3.77 (m, 2H, H-6I, H-
6II), 3.5 (m, 2H, H-2II, H-5I), 3.19 (dd, 1H, J3,4 10.0,
J4,5 10.4, H-4II), 1.86 (s, 3H, NHCOCH3). 13C NMR d
170.69 (NCOCH3), 138.89 (@CH), 138.4–126.64 (Ph),
118.07 (@CH2), 102.44 (CHPh), 97.24 (C-1I), 96.36
(C-1II), 83.10 (C-3II), 81.88 (C-4I), 78.73 (C-2II), 77.99
(C-4II), 75.97 (OCH2Ph), 7.75 (OCH2Ph), 74.17
(OCH2Ph), 72.45 (C-3I), 71.03 (OCH2Ph), 70.49
1.6.3. Procedure C. The mixture after the reaction of 9
(0.15 g, 0.42 mM) with 54 (0.30 g, 0.51 mM) in DMF
(7 mL) and CH2Cl2 (7 mL) in the presence of NIS